Navigation Links
Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering
Date:1/15/2014

LAWRENCEVILLE, N.J., Jan. 15, 2014 /PRNewswire/ -- Celsion Corporation (the "Company") (NASDAQ: CLSN) today announced that it has received commitments from institutional investors to purchase an aggregate of approximately $15 million of the Company's common stock in an at-the-market registered direct offering, led by a dedicated health care fund.

The Company entered into definitive purchase agreements with these investors pursuant to which the Company agreed to sell an aggregate of 3,603,603 shares of its common stock at a per share price of $4.1625.  Additionally, for each share of common stock purchased, investors will receive a Series A Warrant to purchase one-quarter of a share of our common stock at an exercise price of $4.10 per share, which shall be exercisable immediately and expire five years from the date of issuance, and a Series B Warrant to purchase one-quarter of a share of our common stock at an exercise price of $4.10 per share, which shall be exercisable immediately and expire one year from the date of issuance. The closing of the offering is expected to take place on or about January 21, 2014, subject to the satisfaction of customary closing conditions.

The estimated net proceeds to the Company from the offering are expected to be approximately $13.8 million.  With the net proceeds from this offering, the Company projects to have an unaudited cash and investment balance of approximately $57 million.  The Company intends to use the net proceeds from this offering for general corporate purposes.

H.C. Wainwright & Co., LLC  acted as exclusive placement agent in connection with the offering.

A shelf registration statement (File No. 333-183286) relating to the shares issued in the offering has been filed with and declared effective by the Securities and Exchange Commission (the "SEC"
'/>"/>

SOURCE Celsion Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials at the 2013 San Antonio Breast Cancer Conference
2. Celsion Corporation Announces Strategic Loan Facility
3. Celsion Corporation Reports Third Quarter 2013 Financial Results and Provides Business Update
4. Celsion Corporation to Hold Third Quarter 2013 Financial Results Conference Call on Tuesday, November 12, 2013
5. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials to be Presented at the 2013 San Antonio Breast Cancer Conference
6. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
7. Celsion Corporation to Hold Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013
8. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
9. Celsion Corporation Reports Year End 2012 Financial Results and Provides Business Update
10. Celsion Corporation to Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013
11. Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 04, 2015 Research ... addition of Jain PharmaBiotech,s new report "Animal ... their offering. This report describes and ... medicine and pharmaceuticals as well as improvement in ... in the application of biotechnology to manage genetic ...
(Date:8/4/2015)... , Aug. 4, 2015 Among 1,000 U.S. ... yet only half of consumers surveyed are aware of ... ever used use them, according to findings from a ... community service partnership focused on improving the health and ... online survey polled 1,000 men and women, ages 21 ...
(Date:8/3/2015)... Aug. 4, 2015   The Intellectual Property ... world,s leading provider of intelligent information for businesses ... 2015 CMR Pharmaceutical R&D Factbook , the biopharmaceutical ... concerns around declines in R&D, the analysis identifies ... trillion milestone and forecasts sales to reach $1.3 ...
Breaking Medicine Technology:Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Pharma Sales to Grow Beyond $1 Trillion 2
... Maine, Oct. 21, 2011 IDEXX Laboratories, Inc. (NASDAQ: ... quarter of 2011 increased 12% to $301.0 million, from $269.6 ... as defined below, was 8%. Earnings per diluted share ("EPS") ... $0.66, compared to $0.59 for the same period in the ...
... Corporation (OTCBB: CDXC), the creator of pTeroPure®, today announced ... William Spengler to its Board of Directors. Mr. Honig ... board. Barry Honig is a specialist ... Chairman of InterCLICK (ICLK), a $150 million NASDAQ company.  ...
Cached Medicine Technology:IDEXX Laboratories Announces Third Quarter Results 2IDEXX Laboratories Announces Third Quarter Results 3IDEXX Laboratories Announces Third Quarter Results 4IDEXX Laboratories Announces Third Quarter Results 5IDEXX Laboratories Announces Third Quarter Results 6IDEXX Laboratories Announces Third Quarter Results 7IDEXX Laboratories Announces Third Quarter Results 8IDEXX Laboratories Announces Third Quarter Results 9IDEXX Laboratories Announces Third Quarter Results 10IDEXX Laboratories Announces Third Quarter Results 11IDEXX Laboratories Announces Third Quarter Results 12IDEXX Laboratories Announces Third Quarter Results 13IDEXX Laboratories Announces Third Quarter Results 14ChromaDex Announces Appointment of Barry Honig, Michael Brauser and William Spengler to Its Board of Directors 2ChromaDex Announces Appointment of Barry Honig, Michael Brauser and William Spengler to Its Board of Directors 3
(Date:8/4/2015)... ... August 04, 2015 , ... ... examination now offered by the world renowned Beverly Hills facelift surgeon , ... through cosmetic surgery techniques helps individuals to achieve an outer appearance that meets ...
(Date:8/4/2015)... Denver, CO (PRWEB) , ... August 04, 2015 ... ... for skilled nursing homes and other long-term care facilities, today announced details of ... (QAPI) for nursing homes and centers. , Providigm’s QAPI Accreditation program , ...
(Date:8/4/2015)... (PRWEB) , ... August 04, ... ... its HealthCenter personal health record (PHR) product has achieved Office of the ... Inpatient EHR Certification from Drummond Group. HealthCenter delivers the highest quality personal ...
(Date:8/4/2015)... ... ... METTLER TOLEDO has announced an upcoming online symposium entitled ... and Merck. This free online seminar will be held on September 24, ... decisions with limited process understanding. Established methods have been developed to facilitate ...
(Date:8/4/2015)... ... ... The results of a three year clinical trial for the Argus II, a ... blindness, were published on June 23, 2015 in Ophthalmology , the journal of ... more commonly known as the “bionic eye,” is safe and effective for long-term treatment ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:“Bionic Eye” Implant for the Blind Proved Safe and Effective at the End of a Three Year Clinical Trial 2
... National Government Services subsidiary Medicare ... York and Connecticut, INDIANAPOLIS, May 5 WellPoint, ... Inc.,subsidiary was selected by the Centers for Medicare & ... Jurisdiction 13,which includes the states of New York and ...
... kidney disease from high blood pressure did not keep ... of African-Americans studied, according to long-term results of a ... in the Archives of Internal Medicine. , The largest ... the African American Study of Kidney Disease and ...
... more with exclusive summer ... travel packages for 2008., SAN RAFAEL, ... Hotels & Restaurants Group announced today a,series of travel packages for ... KN Tranquility Suite(TM) offers opulent, comfort-inspired,surroundings in the heart of Chicago,s ...
... 5 ConforMIS, Inc., a privately,held company that ... treatment of osteoarthritis and joint damage, today,announced the ... Officer.,The addition fully rounds out the executive team, ... Chief Executive Officer and Phil Licari,as Chief Operating ...
... fewer brain bleeds than aspirin, study finds , , MONDAY, May ... good as aspirin at preventing recurrent stroke and it causes ... Peking University First Hospital in Beijing shows. , The trial ... to 18 months and 359 patients who took aspirin for ...
... prescriptions for $10, more women,s health offerings, and $4 ... BENTONVILLE, Ark., May 5 While health care,costs ... Stores, Inc.,(NYSE: WMT ) is furthering its efforts ... costs and providing ongoing savings,through its pharmacy offerings., ...
Cached Medicine News:Health News:WellPoint Wins Medicare Administrative Contract Worth up to $323 Million 2Health News:Kidney disease worsens in a fourth of African-Americans despite therapy for hypertension 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 2Health News:KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile 3Health News:ConforMIS Completes Executive Team With Addition of CFO 2Health News:Anti-Clotting Drug as Good as Aspirin at Stopping Second Stroke 2Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 2Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 3Health News:Wal-Mart Launches Phase Three of $4 Prescription Program 4
Inquire...
Inquire...
... new QIAvac 24 Plus vacuum manifold allows processing of ... tedious loading and unloading of spin columns into and ... Plus offers: Time savings ... DNA, PCR products, and RNA Convenience ...
... Vac Manifold is available to ... 30 minutes; the manifold is ... and a vacuum regulator with ... vacuum chamber, on/off switch, control ...
Medicine Products: